Author

Maximilian Fuchs

Fraunhofer Institute for Toxicology and Experimental MedicineORCID 0000-0002-8099-9541Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Andreas PichiD· 1 shared Angelika Pfanne· 1 shared Annette Just· 1 shared Arne SchmidtiD· 1 shared Elisa Mohr· 1 shared Jan FiedleriD· 1 shared Kevin SchmidtiD· 1 shared Maria JordaniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Andreas PichORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyScientific ReportsPeer-reviewedJul 16, 2024

SGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation

Kevin Schmidt, Arne Schmidt, Sonja Groß…·Thomas Thum

This study shows SGLT2 inhibitors reduce endothelial to mesenchymal transition and cardiac fibroblast activation through effects on mitochondrial respiration, actin cytoskeleton, and specific transporters.

29 citationstop 2%

humanproteomics

𝕏 PostBluesky